热门资讯> 正文
ImmunoPrecise重新获得纳斯达克最低投标价合规性
2025-07-14 20:19
- ImmunoPrecise Antibodies (NASDAQ:IPA) has regained compliance with Nasdaq.
- The company's stock maintained a closing bid price of at least $1/share for 10 consecutive business days from June 26, 2025, through July 10, 2025.
- IPA shares up 2.7% premarket on Monday.
- Source: Press release
More on ImmunoPrecise
- Seeking Alpha’s Quant Rating on ImmunoPrecise
- Historical earnings data for ImmunoPrecise
- Financial information for ImmunoPrecise
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。